Premium
IGM Biosciences Inc (IGMS)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more
– Imvotamab (CD20 x CD3) trials in rheumatoid arthritis, systemic lupus erythematosus and myositis ongoing; initial clinical data expected by mid-2025 – – IGM-2644 (CD38 x CD3) expected to enter...
MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.64 | 6.77248677249 | 9.45 | 11.62 | 9.45 | 207086 | 10.57223825 | CS |
| 4 | -6 | -37.2902423866 | 16.09 | 16.09 | 8.3765 | 284128 | 10.98063639 | CS |
| 12 | -1.19 | -10.5496453901 | 11.28 | 22.5 | 8.3765 | 323836 | 14.52893981 | CS |
| 26 | 1.66 | 19.6915776987 | 8.43 | 22.5 | 6.1721 | 295550 | 12.08085568 | CS |
| 52 | 3.86 | 61.9582664526 | 6.23 | 22.5 | 5.58 | 305227 | 11.13086113 | CS |
| 156 | -37.76 | -78.9132706374 | 47.85 | 53.92 | 3.81 | 358276 | 17.11242379 | CS |
| 260 | -10.04 | -49.8758072529 | 20.13 | 127.11 | 3.81 | 282026 | 29.54754779 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
